PROFUND ADVISORS LLC

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1129919 BETHESDA, MD

Position in RCKT

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$225,776

+$10,436 QoQ

Shares Held

63,066

+95.3% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,565,563 across 158 Biotechnology names. RCKT ranks #144 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$225,776	63,066	+95.3%	Shares	Sole	2026-04-27
2025-03-31	$215,340	32,285	+7.0%	Shares	Sole	2025-05-08
2024-12-31	$379,123	30,161	+17.2%	Shares	Sole	2025-02-14
2024-09-30	$475,140	25,725	+15.9%	Shares	Sole	2024-11-14
2024-06-30	$477,987	22,201	-56.6%	Shares	Sole	2024-08-13
2024-03-31	$1,377,927	51,148	+48.4%	Shares	Sole	2024-05-08
2023-12-31	$1,033,095	34,471	-15.6%	Shares	Sole	2024-02-14
2023-09-30	$837,241	40,861	-3.9%	Shares	Sole	2023-11-13
2023-06-30	$844,514	42,502	-23.4%	Shares	Sole	2023-08-10
2023-03-31	$950,989	55,516	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.